dsm-firmenich’s US$10M upgrade to modernize nutritional premix production at US facility
Key takeaways
- As part of modernization efforts, dsm-firmenich has invested US$10 million to upgrade its US flagship hub for food, supplement, and infant formula premixes.
- The facility now features optimized GMP zoning, advanced powder technologies, and 35 blenders to improve material flow, safety, and audit readiness.
- The upgrades are designed to help customers meet strict regulatory standards and to offer a “transparent” view of production to foster deeper collaboration.
Upgrading its supply chain for nutrition, health, and beauty, dsm-firmenich has completed a US$10 million modernization program at its US-based flagship premix hub for the Americas, in Schenectady, New York. The Swiss company considers the facility one of North America’s most advanced sites for human food, dietary supplements, and infant formula premixes.
The facility’s expanded material conditioning capabilities include optimized GMP (Good Manufacturing Practices) zoning, advanced powder technologies, and 35 blenders to improve material flow, safety, and audit readiness.
“This investment goes well beyond incremental upgrades or technical improvements — it reflects our commitment to delivering real value for our customers,” says Maximilian Fattinger, VP Premix at dsm-firmenich.
“By taking a generational step forward in premix excellence, we are raising the bar for quality, safety, and reliability, so customers can count on consistent performance and dependable supply.”
Established in 1995, the Schenectady site is designed to raise quality assurance, improve operational efficiency, and enhance audit readiness, while reducing risk and enabling “faster, more reliable commercialization of nutritional products.”
Platform for collaboration
Beyond strengthening premix quality and operations, the flagship Schenectady plant serves as a platform for deeper customer engagement. It offers visitors a “transparent” behind-the-scenes look at the systems, standards, and expertise that underpin each stage of premix production.
The Swiss company considers the facility one of North America’s most advanced sites for human food, dietary supplements, and infant formula premixes.The facility houses 35 blenders, a centralized dispensary, optimized material flow, and advanced powder technologies and material conditioning.
It also features “purpose-built” rooms, controlled environments, and “globally aligned” processes that elevate consistency, compliance, and audit readiness, helping customers meet strict regulatory requirements.
“Together, these upgrades align Schenectady with evolving regulatory and safety expectations and increasingly rigorous customer audits, while helping customers reduce operation risk and maintain continuity as standards evolve,” details dsm-firmenich.
Last October, the supplier inaugurated its modernized pet-only premix facility in Tonganoxie, Kansas, US. This site is equipped with fully automated micro-ingredient additions and fully traceable batch assembly. It is capable of producing for the pet food industry’s “full spectrum of demand,” from basic nutrition to sophisticated functional formulations that are “on par with human supplements.”
